Discovery of New Microbial Collagenase Inhibitors

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Bacterial collagenases are key virulence factors enabling pathogen colonization and infection.
• Targeting bacterial collagenases offers a promising strategy for developing novel anti-infective therapies.
• Multi-drug-resistant bacterial infections pose a significant global health threat.

Purpose of the Study:

• To screen compounds for inhibitory activity against bacterial collagenase A.
• To identify natural compounds with potential as anti-infective agents.
• To elucidate the interaction between collagenase A and inhibitory compounds using molecular docking.

Main Methods:

• A fluorescence resonance energy-transfer (FRET) assay was employed for primary screening of 77 compounds.
• Selected compounds underwent further evaluation to determine their half maximal inhibitory concentration (IC50).
• Molecular docking simulations were performed to analyze enzyme-compound interactions.

Main Results:

• Several natural compounds, including capsaicin, curcumin, and 4',5-dihydroxyflavone, exhibited significant collagenase A inhibitory activity.
• The IC50 values for promising compounds were determined.
• Molecular docking provided insights into the binding mechanisms of these inhibitors.

Conclusions:

• Natural compounds demonstrate potential as effective inhibitors of bacterial collagenase A.
• These findings highlight promising candidates for developing new anti-infective drugs against resistant bacterial strains.
• Further development of these compounds could lead to novel treatments for bacterial infections.